Want to join the conversation?
$BMY 2Q15 Call: Delivered 7% overall sales growth YoverY. For Opdivo, had three early study stops, significant data presented at ASCO, three filings, three approvals, and commercial launches in both US & Europe. In Europe, Opdivo was approved for squamous lung cancer in this week. Expects to complete filing of 57 data in US & Europe in this week.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.